Fresenius Medical Care Announces BEACON-US, Generating Real-world Evidence Supporting High-volume Hemodiafiltration for U.S. Dialysis Patients
July 30, 2026
July 30, 2026
HOMBURG, Germany, July 30 (TNSjou) -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release on July 29, 2026:
* * *
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients
* BEACON-US research initiative is evaluating the clinical outcomes and patient experiences of high-volume hemodiafiltrati . . .
* * *
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients
* BEACON-US research initiative is evaluating the clinical outcomes and patient experiences of high-volume hemodiafiltrati . . .